FDA Approves New Therapy for Dravet Syndrome Fintepla labelling includes a boxed warning stating the drug is associated with valvular heart disease (VHD) and pulmonary…
Dr Lal PathLabs collaborates with ORDI to sensitise India on rare diseases The association is to raise awareness for the 7,000 documented rare diseases across nine cities
